Safety and efficacy of trastuzumab emtansine (TDM-1) in a patient on hemodialysis for renal failure by A. Falcón González, P. Estévez Garcia, A. Sánchez Gastaldo, I. Sánchez Simón, J. Salvador Boffil, M. Ruiz Borrego

Subjects: “…Trastuzumab emtansine…”
Get full text

The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells by Peipei Liu, Jiajun Fan, Ziyu Wang, Wenjing Zai, Ping Song, Yongping Li, Dianwen Ju

Subjects: “…Trastuzumab emtansine…”
Get full text

Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report by Patricia Miranda Romero, Roberto Marín Gil

Subjects: Get full text

Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1) by Alessandro D. Santin, Stefania Bellone, Natalia Buza, Peter E. Schwartz

Subjects: Get full text

Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study by Eyyup Cavdar, Kubilay Karaboyun, Yakup Iriagac, Okan Avci, Erdoğan Selcuk Seber

Subjects: Get full text

Developments in the Management of Metastatic HER2-Positive Breast Cancer: A Review by Julie Lebert, Evan J. Lilly

Subjects: Get full text

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases by Matthew N. Mills, Chelsea Walker, Chetna Thawani, Afrin Naz, Nicholas B. Figura, Sergiy Kushchayev, Arnold Etame, Hsiang-Hsuan Michael Yu, Timothy J. Robinson, James Liu, Michael A. Vogelbaum, Peter A. Forsyth, Brian J. Czerniecki, Hatem H. Soliman, Hyo S. Han, Kamran A. Ahmed

Subjects: “…Trastuzumab emtansine…”
Get full text

Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation by Mark Barok, Maija Puhka, Gyorgy Vereb, Janos Szollosi, Jorma Isola, Heikki Joensuu

Subjects: Get full text

Efficacy and safety of Trastuzumab Emtansine in treating human epidermal growth factor receptor 2-positive metastatic breast cancer in Chinese population: a real-world multicenter... by Miao He, Miao He, Wen Zhao, Peng Wang, Wenhuan Li, Hanhan Chen, Zonghuai Yuan, Guangye Pan, Hong Gao, Lijun Sun, Jiahui Chu, Li Li, Yu Hu

Subjects: “…trastuzumab emtansine…”
Get full text

Plasma Exchange May Enhance Antitumor Effects by Removal of Soluble Programmed Death-Ligand 1 and Extracellular Vesicles: Preliminary Study by Kazumasa Oya, Larina Tzu-Wei Shen, Kazushi Maruo, Satoshi Matsusaka

Subjects: Get full text

Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab by Tatiana Strava Corrêa, Gustavo Duarte Ramos Matos, Marcos Segura, Carlos Henrique dos Anjos

Subjects: Get full text

CLINICAL CASE OF SUCCESFUL APPLICATION OF KADSYLA APPLICATION IN METASTATIC HER2 POSITIVE BREAST CANCER by D. D. Sakaeva

Subjects: Get full text

Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer by Oğuzcan Kınıkoğlu, Hatice Odabas, Yunus Emre Altıntaş, Anıl Yıldız, Burçin Çakan, Goncagül Akdağ, Sedat Yıldırım, Hamit Bal, Tuğba Kaya, Salih Tünbekici, Deniz Işık, Tuğba Başoğlu, Mahmut Emre Yıldırım, Nedim Turan

Subjects: Get full text

Ado-Trastuzumab Emtansine-Induced Pulmonary Toxicity: A Single-Institution Retrospective Review by Heidi Egloff, Kelley M. Kidwell, Anne Schott

Subjects: “…Ado-trastuzumab emtansine…”
Get full text

Trastuzumab Emtansine for the Treatment of HER-2 Positive Carcinoma Ex-pleomorphic Adenoma Metastatic to the Brain: A Case Report by Ihab Hassanieh, Ihab Hassanieh, Lara Hilal, Lara Hilal, Karine A. Al Feghali, Karine A. Al Feghali, Ibrahim Khalifeh, Bassem Youssef, Bassem Youssef

Subjects: Get full text

Improving Receptor-Mediated Intracellular Access and Accumulation of Antibody Therapeutics—The Tale of HER2 by Jeffrey V. Leyton

Subjects: Get full text

Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients by Alexey A. Larionov

Subjects: Get full text

Enhanced Characterization of Lysine-Linked Antibody Drug Conjugates Enabled by Middle-Down Mass Spectrometry and Higher-Energy Collisional Dissociation-Triggered Electron-Transfer/... by Eleanor Watts, Aarti Bashyal, Sean D. Dunham, Christopher M. Crittenden, Jennifer S. Brodbelt

Subjects: Get full text

Phase II study (KAMELEON) of single‐agent T‐DM1 in patients with HER2‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma by Elisabeth G. E. deVries, Josef Rüschoff, Martijn Lolkema, Josep Tabernero, Luca Gianni, Emile Voest, Derk Jan A. deGroot, Daniel Castellano, Gilles Erb, Julia Naab, Margarita Donica, Regula Deurloo, Michiel S. van derHeijden, Giuseppe Viale

Subjects: Get full text

A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive brea... by Tejal A. Patel, Joe E. Ensor, Sarah L. Creamer, Toniva Boone, Angel A. Rodriguez, Poly A. Niravath, Jorge G. Darcourt, Jane L. Meisel, Xiaoxian Li, Jing Zhao, John G. Kuhn, Roberto R. Rosato, Wei Qian, Anna Belcheva, Mary R. Schwartz, Virginia G. Kaklamani, Jenny C. Chang

Subjects: Get full text